Schrödinger, Inc. ($SDGR)
Akinsanya Karen – President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships
Shares
2,206
Price
$11.99
Total Value
$26,454.35
Nearby Earnings
Feb 25, 2026
EPS:Est: -0.13
Transaction Details
| Insider | Akinsanya Karen |
|---|---|
| Title | President, Head of Therapeutics R&D and Chief Strategy Officer, Partnerships |
| Transaction Date | Mar 2, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 3, 2026 |
| Shares Sold | 2,206 |
| Price per Share | $11.99 |
| Total Value | $26,454.35 |
| Shares Owned After | 71,322 |
| Derivative | No |
| Accession Number | 0001797672-26-000001 |
| Document | View SEC Filing |